Neurol. praxi. 2007;8(5):295-298

Poruchy chování u pacientů s Alzheimerovou chorobou

doc. MUDr. Roman Jirák, CSc.
Psychiatrická klinika 1. LF UK a VFN Praha

Jedním ze tří základních okruhů postižení u ACh i dalších demencí jsou (kromě poruch kognitivních funkcí a aktivit denního života) tzv. behaviorální a psychologické příznaky demence. Mezi tyto poruchy náleží postižení emotivity (deprese, úzkost aj.), postižení spánku a cyklu spánek – bdění, a také poruchy chování. Tyto poruchy bývají někdy, hlavně ve středních a pokročilých stadiích demence, nejnápadnější i nejvíce zatěžující příznaky. Mohou mít různou podobu. Velmi častá je agitovanost – neustálý, někdy jen mírný neklid. K poruchám chování se také druží doprovodné psychotické příznaky jako: bludy, halucinace, misinterpretace. Jsou probrány možnosti ovlivnění neklidu alzheimerovských pacientů, rozebrány možnosti farmakoterapeutických zásahů.

Keywords: Alzheimerova choroba, antipsychotika, demence, chování, neklid

Published: December 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jirák R. Poruchy chování u pacientů s Alzheimerovou chorobou. Neurol. praxi. 2007;8(5):295-298.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bayer A, Reban J (eds.): Alzheimer's disease and related dementias. Medea Press, 2004, 330 s.
    2. Brodaty H, Ames D, Snowden J et al. A randomized placebo-controlled trial of risperidone for the treatmento of agression, agitation, and psychosis of dementia. J Clin Psychiatry, 2003; 64: 134-143. Go to original source... Go to PubMed...
    3. Caltagirone C, Bianchetti A, Di Luca M et al. Guidelines for the treatment of Alzheimer´s disease from the Italian Association of Psychogeriatrics. Drugs & Aging 2005; 22 Suppl. 1: 1-26. Go to original source... Go to PubMed...
    4. Jirák R, Koukolík F. Demence. Galen, Praha, 2004, 335 s.
    5. Jirák R, Borzová C, Konrád J, Franková V, Spousta S. Demence. In: Psychiatrie, doporučené postupy psychiatrické péče II, ed. Raboch J, Anders M, Praško J. Hellerová P. Infopharm, Praha, 2006, s. 22-37.
    6. Katz I, Jeste DV, Mintzer JE et al. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry,1999; 60: 107-115. Go to original source... Go to PubMed...
    7. Longeran E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev. 2002; 2: CD002852. Go to original source...
    8. Meehan KM, Wang H, David SR et al. Comparison of rapidly acting intramuscular olanzapine, lorazepam, and placebo: a doubleblind, randomized study in acutely agitated patients with dementia. Neuropsychopharmacology, 2002; 26: 494-504. Go to original source... Go to PubMed...
    9. Schneider LS, Pollock VE, Lyness SA. A metaanalysis of controlled trials of neuroleptic treatment in dementia. J AM Geriatr Soc. 1990; 38: 553-563. Go to original source... Go to PubMed...
    10. Street JS, Clark WS, Gannon KS et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blidn, randomized, placebo-controlled trial. Arch Gen Psychiatry, 2000; 57: 968-976. Go to original source... Go to PubMed...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.